Загрузка...
Assessing the mechanisms of cholesteryl ester transfer protein inhibitors
Cholesteryl ester transfer protein (CETP) inhibitors are a new class of therapeutics for dyslipidemia that simultaneously improve two major cardiovascular disease (CVD) risk factors: elevated low-density lipoprotein (LDL) cholesterol and decreased high-density lipoprotein (HDL) cholesterol. However,...
Сохранить в:
| Опубликовано в: : | Biochim Biophys Acta Mol Cell Biol Lipids |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6239860/ https://ncbi.nlm.nih.gov/pubmed/28911944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2017.09.004 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|